Wednesday, March 28, 2018 3:24:47 PM
As I have gotten to know the company and the Officers and their style in regards of PR and MGMT and vision I have become EXTREMELY one-sided that a MEGA B DEAL is in the works. I will back that up by stating they are very accurate in what they have told shareholders over time and yes there are delays and yes there are lateral movements that are always needed as everyone has to sidestep and make adjustments on the fly, but overall the big picture they are dead on. If you reread many of the PR's in the past year or two you can see they had their vision set. The vision has been to stay nimble and make sure each step is a light footed step as they build value long term. They could have easily put all eggs in one ABSSSI basket to move to phase 3 but we would be probably just ending it this past year and have no other movement.
Instead they go with Dr. B's "ANCHORING" philosophy and finish several smaller trials that were done for more of a PoC type feel all the while validating earlier trials in regards to Brilacidin. So now...they have an enormous playing field for B. Not just Antibiotic...but the entire IBD field is in play now, and ontop of that the anti-inflamatory OM is gonna be a blockbuster and we are first in line and now they are reformulating or atleast working with CDA interested parties to show them if they work with us we have more DERMATOLOGY indications with B too...
You cannot deny and no one here can that Brilacidin could be a multiple blockbuster within a blockbuster.
It takes one VALIDATION from BP or a 3rd Party to start the domino effect or snowball effect. If they get that and get this thing moving, there is just too much packed in to stop it.
And then we can maybe move to Prurisol :)
And then we can maybe discuss Kevetrin if we successfully reformulate to ORAL!
If Kevetrin Oral is a success, no one here will be able to understand the value that drug will bring if it does what it is supposed to do. Gene P53 is the "Guardian Angel" of the human geome... ENOUGH SAID.
We will see who is right and who is wrong in the end. I keep buying and do not worry about the day to day - week to week - month to month price ---- I just keep adding as evertything in MY OPINION is exactly as they have said and nothing has failed. FAILED - meaning the drug does not work and is toxic.
All drugs do what they have said they will do, but a couple do need reformulation for optical dosing. That is part of BIO. Atleast IPIX has a TON of drugs in a TON of indications.
Good luck.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM